Arcellx, Inc. (ACLX)
63.39
-1.81
(-2.78%)
USD |
NASDAQ |
Jan 02, 16:00
63.39
0.00 (0.00%)
After-Hours: 20:00
Arcellx EPS Diluted (TTM): -3.918 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Gilead Sciences, Inc. | 6.456 |
| Johnson & Johnson | 10.36 |
| Amicus Therapeutics, Inc. | -0.0446 |
| Relmada Therapeutics, Inc. | -1.797 |
| Invivyd, Inc. | -0.4735 |